Comparison of the expression and function of Lin28A and Lin28B in colon cancer

Oncotarget. 2016 Nov 29;7(48):79605-79616. doi: 10.18632/oncotarget.12869.

Abstract

Lin28A and Lin28B are highly conserved RNA binding proteins with similar structure and functions. Recent studies demonstrated that both of them act as oncogenes and promote cancer progression. However, few researches compared the expression and functions of both oncogenes in human malignant tumors at same time. Additionally, although the expression and role of Lin28B in colon cancer is frequently reported, the expression and functions of Lin28A in colon cancer are largely unknown. In this study, we have systematically evaluated the expressional pattern, mutation status and correlation of both Lin28A and Lin28B in colon cancer tissues for the first time, and compared the roles of Lin28A and Lin28B in the proliferation, migration, invasion and apoptosis of colon cancer cells in vitro. We have showed that they are co-expressed and have functional similarities, however, the molecular mechanisms underlying their similar functions may not be identical. This study contributes to clarify the similarities and differences of Lin28A and Lin28B in colon cancer progression.

Keywords: Lin28A; Lin28B; colon cancer.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / pharmacology
  • Apoptosis
  • Cell Movement
  • Cell Proliferation
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / genetics
  • Colonic Neoplasms / metabolism*
  • Colonic Neoplasms / pathology
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Fluorouracil / pharmacology
  • Gene Expression Regulation, Neoplastic
  • HCT116 Cells
  • Humans
  • Middle Aged
  • Neoplasm Invasiveness
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism*
  • Signal Transduction
  • Transfection

Substances

  • Antimetabolites, Antineoplastic
  • LIN28B protein, human
  • RNA-Binding Proteins
  • Fluorouracil